(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault - 2The Craft of Do-It-Yourself Home Stylistic layout: Change Your Space
- 3What is Fusarium graminearum, the fungus a Chinese scientist pleaded guilty to smuggling into the US?
- 410 Picturesque Campgrounds That Will Raise Your Outside Involvement with American
- 5Japanese H3 rocket fails during launch of navigation satellite (video)
- 4 Home Rec center Hardware Decisions for Little Spaces
- How Mars 'punches above its weight' to influence Earth's climate
- Mysterious bright blue cosmic blasts triggered by black holes shredding stars, scientists say. 'It's definitely not just an exploding star.'
- Former Peruvian President Pedro Castillo sentenced for conspiracy
- Solar storms can trigger auroras on Earth. This star’s explosion could destroy a planet’s atmosphere
- Army commander convicted of Guinea stadium massacre dies in prison
- The cave was pitch black – so to create this magical underwater shot, the photographer had to use all his camera expertise...
- Doctors thought he had cancer. An offhand suggestion led to a rare diagnosis.
- Muslim Brotherhood stole half a billion dollars in Gaza donations, Arab sources reveal
